Etodolac (Etodolac) - Summary

ETODOLAC SUMMARY

ETODOLAC TABLETS

Etodolac is a pyranocarboxylic acid chemically designated as (±) 1, 8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]indole-1-acetic acid.

Etodolac is indicated for acute and long-term use in the management of signs and symptoms of osteoarthritis. Etodolac is also indicated for the management of pain.

ETODOLAC NEWS HIGHLIGHTS

Published Studies Related to Etodolac

Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. [2007.03]

Etodolac versus dexamethasone effect in reduction of postoperative symptoms following surgical endodontic treatment: a double-blind study. [2006.06]

more>>

Clinical Trials Related to Etodolac

Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM) [Terminated]

Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [Terminated]

Evaluation of Stepped Care for Chronic Pain in Iraq and Afghanistan Veterans

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery: an Intervention to Decrease Immune Suppression, Metastatic Potential and Cancer Recurrence [Not yet recruiting]

Regimen for the Treatment of Cachexia in Subjects With NSCLC [Recruiting]

more>>